Canadian Institutes of Health Research
Government of Canada Symbol

6th Annual NICHD-IHDCYH Summer Institute in Maternal-Fetal Pharmacology

CIHR
Department of Health & Human Services-USA NICHD

July 11-17, 2010
Harbourtowne Conference Centre, St. Michaels, Maryland

Return to Welcome Page

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH) and the Institute of Human Development, Child and Youth Health (IHDCYH) of the Canadian Institutes of Health Research (CIHR) are pleased to announce their 6th annual Summer Institute in Maternal-Fetal Pharmacology. The Institute will be held from July 11-17, 2010, at the Harbourtowne Conference Centre, St. Michaels, Maryland.

Important Dates

Application deadline April 1st, 2010
Notice of decision May 15th, 2010
Confirmation of participation
(Successful applicants)
June 1st, 2010
Summer Institute 2010 Start date: Sunday July 11th, 2010 (7pm)
End date: Saturday July 17th, 2010 (12pm)

Course Format

This unique training opportunity features a distinguished international faculty to discuss important topics around therapeutics during pregnancy, the perinatal period, and lactation. Presently, the pregnant mother and her unborn or newborn infant are rarely included in therapeutic studies, leading to "orphaning" from the benefits of drug therapy. The main objective of the Summer Institute is to foster the development of a critical mass of researchers in this neglected area. The course format will combine expert lectures with small-group interactions and hands-on learning to encourage problem-based learning. The course includes preparatory work and assignments, which will be sent to participants one month ahead of time.

Eligibility

The Summer Institute is open to participants from the US, Canada, and low- and middle-income countries.

The applicants must:

  1. Be graduate students, post-doctoral fellows, or clinical and non-clinical scientists (including physicians, pharmacists, nurses, pharmacologists, and toxicologists) at the early faculty stage of their career;
  2. Be actively engaged in research or enrolled in a formal research training program at the MSc, PhD, or post-doctoral level;
  3. Have demonstrated research interest in maternal-fetal pharmacology;
  4. Agree to attend the full duration of the week-long Institute.

How to Apply

The applicants must provide the following information:

  1. Curriculum vitae (CIHR Common CV or NIH Biographical Sketch are acceptable);
  2. One letter of recommendation from their research supervisor, faculty mentor, or Department head;
  3. A short cover letter (500 words or less) stating the following:
    1. Their general research interest;
    2. How the course fits with their planned career path and research;
    3. How their previous training relates to the Summer Institute;
    4. What they expect from and can contribute to the Summer Institute.

Applications must be submitted electronically to IHDCYH-IDSEA@cihr-irsc.gc.ca by April 1st, 2010.

Selection

An Institute faculty committee will select up to 20 students based on research interests, research training and experience, and potential for applying the knowledge and experience gained during the course. A letter of recommendation from a supervisor will help determine the applicant's potential impact in this field of research. The notice of decision will be sent by email to applicants by May 15th, 2010.

Travel expenses

NICHD and IHDCYH will cover the following costs:

  • Lowest price economy air ticket from applicant's home (up to a maximum of $1,500 USD);
  • Hotel accommodation for 6 nights at the Harbourtowne Conference Centre;
  • All meals on course days.

The participant is responsible for any additional meals, transportation, or incidental expenses.

Once successful applicants have confirmed their participation (deadline June 1st, 2010), they will receive detailed travel and lodging information from IHDCYH.

To send your application or for questions on the 6th Annual NICHD-IHDCYH Summer Institute in Maternal-Fetal Pharmacology, please contact Anick Lambert or Lindsay Wallace by email: IHDCYH-IDSEA@cihr-irsc.gc.ca or by phone: 514-412-4414.

DHHS and NIH are Equal Opportunity Employers.

Return to Welcome Page